Lipid lowering for primary prevention Journal Articles

authors

• Yusuf, Salim
• Lonn, Eva
• Bosch, Jackie

status

• published 

publication date

• April 2009

has subject area

• 11 Medical and Health Sciences (FoR)
• Aged (MeSH)
• Cardiovascular Diseases (MeSH)
• Cause of Death (MeSH)
• Cholesterol, LDL (MeSH)
• Female (MeSH)
• Fluorobenzenes (MeSH)
• General & Internal Medicine (Science Metrix)
• Humans (MeSH)
• Hydroxymethylglutaryl-CoA Reductase Inhibitors (MeSH)
• Hyperlipidemias (MeSH)
• Male (MeSH)
• Meta-Analysis as Topic (MeSH)
• Primary Prevention (MeSH)
• Proportional Hazards Models (MeSH)
• Pyrimidines (MeSH)
• Randomized Controlled Trials as Topic (MeSH)
• Research Design (MeSH)
• Rosuvastatin Calcium (MeSH)
• Secondary Prevention (MeSH)
• Sulfonamides (MeSH)
• Treatment Outcome (MeSH)

published in

• The Lancet  Journal

keywords

• Aged
• Cardiovascular Diseases
• Cause of Death
• Cholesterol, LDL
• Female
• Fluorobenzenes
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors
• Hyperlipidemias
• Male
• Meta-Analysis as Topic
• Primary Prevention
• Proportional Hazards Models
• Pyrimidines
• Randomized Controlled Trials as Topic
• Research Design
• Rosuvastatin Calcium
• Secondary Prevention
• Sulfonamides
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1016/s0140-6736(09)60357-3

PubMed ID

• 19345816

start page

• 1152

end page

• 1155

volume

• 373

issue

• 9670